Literature DB >> 33643578

Rapid releasing naproxen Liqui-Pellet using effervescent agent and neusilin US2.

Matthew Lam1, Kofi Asare-Addo2, Ali Nokhodchi1.   

Abstract

OBJECTIVES: Liqui-Mass technology has shown promising advantages in terms of commercial production and formulation manipulation. This study attempts to further explore the potential of enhanced drug release of effervescent Liqui-Pellet by optimizing certain parameters.
MATERIALS AND METHODS: In the current study, pellets containing co-solvent, naproxen, coating and carrier materials were prepared via extrusion and spheronisation (Liqui-Pellet). Parameters investigated included polysorbate 80 concentration (as a co-solvent), water content and the presence or absence of neusilin US2 as part of the new binary carrier mixture approach.
RESULTS: It was found that the success of the Liqui-Pellet production was determined by the amount of polysorbate 80 and water used, where above a certain limit, agglomeration occurred, and the formulation failed. Liqui-Pellet formulation showed an excellent flow, narrow size distribution and was robust to pass friability testing. The key findings in the investigation were that the Liqui-Pellet was capable of a remarkably fast drug release, and 100% drug release achieved within 20 min at pH 1.2, wherein naproxen has been known to be practically insoluble in such pH.
CONCLUSION: Liqui-Pellets display the potential to enhance explosive dissolution where a combination of effervescent powders and binary carriers with the high surface area were used. Furthermore, X-ray microtomography revealed that the pellets were very uniform and homogenous.

Entities:  

Keywords:  Coating; Excipients; Liqui-Mass system; Rapid release; Solubility; X-ray tomography

Year:  2021        PMID: 33643578      PMCID: PMC7894642          DOI: 10.22038/ijbms.2020.51697.11729

Source DB:  PubMed          Journal:  Iran J Basic Med Sci        ISSN: 2008-3866            Impact factor:   2.699


  19 in total

Review 1.  Modeling and comparison of dissolution profiles.

Authors:  P Costa; J M Sousa Lobo
Journal:  Eur J Pharm Sci       Date:  2001-05       Impact factor: 4.384

2.  Comparison of in vitro dissolution profiles by ANOVA-based, model-dependent and -independent methods.

Authors:  N Yuksel; A E Kanik; T Baykara
Journal:  Int J Pharm       Date:  2000-11-19       Impact factor: 5.875

3.  Extrusion and spheronization in the development of oral controlled-release dosage forms.

Authors: 
Journal:  Pharm Sci Technolo Today       Date:  1999-04

Review 4.  Drug release from liquisolid systems: speed it up, slow it down.

Authors:  Ali Nokhodchi; Christina M Hentzschel; Claudia S Leopold
Journal:  Expert Opin Drug Deliv       Date:  2011-01-12       Impact factor: 6.648

5.  Oral controlled release optimization of pellets prepared by extrusion-spheronization processing.

Authors:  R Bianchini; C Vecchio
Journal:  Farmaco       Date:  1989-06

6.  The characterization of wet powder masses suitable for extrusion/spheronization.

Authors:  P J Harrison; J M Newton; R C Rowe
Journal:  J Pharm Pharmacol       Date:  1985-10       Impact factor: 3.765

7.  An alternative method to the evaluation of similarity factor in dissolution testing.

Authors:  P Costa
Journal:  Int J Pharm       Date:  2001-06-04       Impact factor: 5.875

8.  The influence of hydroalcoholic media on the performance of Grewia polysaccharide in sustained release tablets.

Authors:  E I Nep; M H Mahdi; A O Adebisi; C Dawson; K Walton; P J Bills; B R Conway; A M Smith; K Asare-Addo
Journal:  Int J Pharm       Date:  2017-09-10       Impact factor: 5.875

9.  In vitro release evaluation of hydrocortisone liquisolid tablets.

Authors:  S Spireas; S Sadu; R Grover
Journal:  J Pharm Sci       Date:  1998-07       Impact factor: 3.534

10.  Optimising the release rate of naproxen liqui-pellet: a new technology for emerging novel oral dosage form.

Authors:  Matthew Lam; Taravat Ghafourian; Ali Nokhodchi
Journal:  Drug Deliv Transl Res       Date:  2020-02       Impact factor: 4.617

View more
  1 in total

1.  Liqui-Tablet: the Innovative Oral Dosage Form Using the Newly Developed Liqui-Mass Technology.

Authors:  Matthew Lam; Kofi Asare-Addo; Ali Nokhodchi
Journal:  AAPS PharmSciTech       Date:  2021-03-01       Impact factor: 3.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.